Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
PU.1 is an Ets family transcription factor that is essential for fetal liver hematopoiesis. We have generated a PU.1gfp reporter strain that allowed us to examine the expression of PU.1 in all hematopoietic cell lineages and their early progenitors. Within the bone marrow progenitor compartment, PU.1 is highly expressed in the hematopoietic stem cell, the common lymphoid progenitor, and a proportion of common myeloid progenitors (CMPs). Based on Flt3 and PU.1 expression, the CMP could be divided into three subpopulations, Flt3+ PU.1hi, Flt3− PU.1hi, and Flt3− PU.1lo CMPs. Colony-forming assays and in vivo lineage reconstitution demonstrated that the Flt3+ PU.1hi and Flt3− PU.1hi CMPs were efficient precursors for granulocyte/macrophage progenitors (GMPs), whereas the Flt3− PU.1lo CMPs were highly enriched for committed megakaryocyte/erythrocyte progenitors (MEPs). CMPs have been shown to rapidly differentiate into GMPs and MEPs in vitro. Interestingly, short-term culture revealed that the Flt3+ PU.1hi and Flt3− PU.1hi CMPs rapidly became CD16/32high (reminiscent of GMPs) in culture, whereas the Flt3− PU.1lo CMPs were the immediate precursors of the MEP. Thus, down-regulation of PU.1 expression in the CMP is the first molecularly identified event associated with the restriction of differentiation to erythroid and megakaryocyte lineages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1. Generation and validation of a PU.1gfp reporter strain. (A) The targeted PU.1 gfp locus is shown with the exons indicated as boxes and the introns as black lines. Coding regions are in gray and nontranslated regions are white. Arrows indicate direction of translation from initial methionine. pA, polyadenylation signal sequence; circles, frt sites; triangles, loxP sites; stop, stop codon; splice acc., splice acceptor. The targeted allele translates full-length PU.1 and GFP from the same mRNA transcript. (B) GFP expression in PU.1 gfp/+ BM. Cells were stained for CD19 (B cells) and Mac-1 (myeloid cells). (C) GFP expression in B cells and macrophage/granulocytes of adult spleen of +/+, PU.1 gfp/+, and PU.1 gfp/gfp mice. (D) Quantitation of mean fluorescence of B cells (CD19+ B220+), granulocytes (Mac-1+ Gr.1high), and immature myeloid cells (Mac-1+ Gr-1–intermediate [Gr.1int]) from BM and spleen. n = 4–10 mice per group. Relative mean fluorescence was determined relative to identically gated C57BL/6 cells and is shown in arbitrary units. (E) Western blotting for PU.1 in BM Mac-1+/Gr.1+ myeloid cells (BMM), CD19+ B220+ spleen B cells, and CD4+ T lymphocytes. β actin was a loading control. (F) Determination of PU.1 and GFP stability in splenocytes. Cells were cultured for up to 12 h in the protein synthesis inhibitor cyclohexamide, and equivalent cell numbers were assayed for PU.1, GFP, and β actin levels by Western blotting. The calculated half-life of the proteins is indicated (left).](https://figures.cochat.ai/paper-figures/56d2c214d1264eb48b4838aa4422e111/dynamic-regulation-of-pu-1-expression-in-multipotent-hematopoietic-progenitors-figure-1.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Spi-1 promotes myelopoiesis and B lymphopoiesis (3–5).”
From Spi-1/PU.1 activates transcription through clustered DNA occupancy in erythroleukemia (2012) · cites this paper as [5]
In the citing paper
“PU.1 directs commitment to the neutrophil and monocyte lineages19,20, whereas GATA1 promotes the differentiation of erythroid cells21 and eosinophil granulocytes22–24.”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617 · cited 12×
“1 mRNA was expressed at different levels by different hematopoietic progenitor populations (2, 26).”
BackgroundInfluentialRequirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130
Biology of Hematopoietic Stem Cells and Progenitors: Implications for Clinical Application
Kondo, M., Wagers, A. J., Manz, M. G., Prohaska, S. S., Scherer, D. C., Beilhack, G. F., Shizuru, J. A., & Weissman, I. L. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141007 · Cited by 997 · cited 1×
“It has been postulated that the HSC differentiates to either a clonogenic common lymphoid progenitor (CLP) that produces lymphocytes and DCs (1) or a common myeloid progenitor (CMP) capable of giving rise to the erythromyeloid lineages.”
BackgroundCD4 and CD8 Expression by Dendritic Cell Subtypes in Mouse Thymus and Spleen
Vremec, D., Pooley, J., Hochrein, H., Wu, L., & Shortman, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.2978 · Cited by 811
Self-citationRegulation of B lymphocyte and macrophage development by graded expression of PU.1
DeKoter, R. P., & Singh, H. (2000) · Science · doi:10.1126/science.288.5470.1439 · Cited by 749
Multilineage gene expression precedes commitment in the hemopoietic system.
Hu, M., Krause, D., Greaves, M., Sharkis, S., Dexter, M., Heyworth, C., & Enver, T. (1997) · Genes & Development · doi:10.1101/gad.11.6.774 · Cited by 729 · cited 1×
“All other primer sets have been described (48).”
BackgroundKarsunky, H., Merad, M., Cozzio, A., Weissman, I. L., & Manz, M. G. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030323 · Cited by 602 · cited 6×
“4 A, all of the Flt3 CMPs were PU.1hi, but the Flt3 CMPs could be further divided into two fractions based on differing GFP expression.”
BackgroundResultInfluentialTranscriptional regulation of erythropoiesis: an affair involving multiple partners
Cantor, A. B., & Orkin, S. H. (2002) · Oncogene · doi:10.1038/sj.onc.1205326 · Cited by 594
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.
Rosenbauer, F., Wagner, K., Kutok, J. L., Iwasaki, H., Le Beau, M. M., Okuno, Y., Akashi, K., Fiering, S., & Tenen, D. G. (2004) · Nature Genetics · doi:10.1038/ng1361 · Cited by 506 · cited 2×
“Deletion of a distal enhancer 14-kb upstream of the start of transcription was recently shown to reduce expression to 20% that of wildtype cells (9).”
Background
Research works printed but not linked: 3
- 2004, Blood., 104, 3437
- 1996, Curr. Top. Microbiol. Immunol., 211, 137
- 1995, Oncogene., 11, 1549
Cited by
The generation of antibody-secreting plasma cells
Nutt, S. L., Hodgkin, P. D., Tarlinton, D. M., & Corcoran, L. M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3795 · Cited by 1,454
Self-citationIdentification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic Potential
Adolfsson, J., Månsson, R., Buza-Vidas, N., Hultquist, A., Liuba, K., Jensen, C. T., Bryder, D., Yang, L., Borge, O.-J., Thoren, L. A. M., et al. (2005) · Cell · doi:10.1016/j.cell.2005.02.013 · Cited by 1,236
“However, when compared to LSK Flt3−, cells very few Flt3− CMPs were found to give rise to mixed MkE and GM colonies, and in agreement with recent studies (Nutt et al., 2005), the Lin−IL7Rα−Sca-1−c-kit+CD34+FcR−Flt3− candidate CMP population gave rise to primarily pure GM or MkE colonies.”
ResultYamamoto, R., Morita, Y., Ooehara, J., Hamanaka, S., Onodera, M., Rudolph, K. L., Ema, H., & Nakauchi, H. (2013) · Cell · doi:10.1016/j.cell.2013.08.007 · Cited by 750
“However, the issue of a branching point of MkE lineage remains controversial (Forsberg et al., 2006; Lai et al., 2005; Nutt et al., 2005).”
Dissecting cell identity via network inference and in silico gene perturbation
Kamimoto, K., Stringa, B., Hoffmann, C. M., Jindal, K., Solnica-Krezel, L., & Morris, S. A. (2023) · Nature · doi:10.1038/s41586-022-05688-9 · Cited by 677
Pronk, C. J. H., Rossi, D. J., Månsson, R., Attema, J. L., Norddahl, G. L., Chan, C. K. F., Sigvardsson, M., Weissman, I. L., & Bryder, D. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.07.005 · Cited by 671
“1 in such cells was associated with granulocytic/macrophage offspring, whereas cells with low expression mainly produced megakaryocytic/ erythroid progeny, with no evident hierarchical relationship in between those cells (Nutt et al., 2005).”
BackgroundMultilineage Transcriptional Priming and Determination of Alternate Hematopoietic Cell Fates
Laslo, P., Spooner, C. J., Warmflash, A., Lancki, D. W., Lee, H.-J., Sciammas, R., Gantner, B. N., Dinner, A. R., & Singh, H. (2006) · Cell · doi:10.1016/j.cell.2006.06.052 · Cited by 632
Transcription factors in myeloid development: balancing differentiation with transformation
Rosenbauer, F., & Tenen, D. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2024 · Cited by 606
“1 (also known as SPI1) have shown that CMPs include at least two separate subpopulation”
BackgroundNATURAL KILLER CELL DEVELOPMENTAL PATHWAYS: A Question of Balance
Di Santo, J. P. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090700 · Cited by 448
Kirstetter, P., Anderson, K., Porse, B. T., Jacobsen, S. E. W., & Nerlov, C. (2006) · Nature Immunology · doi:10.1038/ni1381 · Cited by 446
Myeloid Lineage Commitment from the Hematopoietic Stem Cell
Iwasaki, H., & Akashi, K. (2007) · Immunity · doi:10.1016/j.immuni.2007.06.004 · Cited by 394
The Transcriptional Regulation of B Cell Lineage Commitment
Nutt, S. L., & Kee, B. L. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.010 · Cited by 387
Self-citationTranscription factor profiling in individual hematopoietic progenitors by digital RT-PCR
Warren, L., Bryder, D., Weissman, I. L., & Quake, S. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608512103 · Cited by 369
DEVELOPMENT OF HUMAN LYMPHOID CELLS
Blom, B., & Spits, H. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090612 · Cited by 339
Platelets and cancer: a casual or causal relationship: revisited
Menter, D. G., Tucker, S. C., Kopetz, S., Sood, A. K., Crissman, J. D., & Honn, K. V. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9498-0 · Cited by 316
Monocytes in the Tumor Microenvironment
Ugel, S., Canè, S., De Sanctis, F., & Bronte, V. (2021) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-013058 · Cited by 314
Arinobu, Y., Mizuno, S.-I., Chong, Y., Shigematsu, H., Iino, T., Iwasaki, H., Graf, T., Mayfield, R., Chan, S., Kastner, P., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.07.004 · Cited by 309
Megakaryocyte development and platelet production
Deutsch, V. R., & Tomer, A. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06215.x · Cited by 311
“One of the initial events during MK/E lineage restriction is downregulation of PU.1, the main TF responsible for myeloid cell differentiation (Nutt et al, 2005) and upregulation of GATA-1.”
BackgroundPU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis
Dakic, A., Metcalf, D., Di Rago, L., Mifsud, S., Wu, L., & Nutt, S. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050075 · Cited by 297
Self-citationTranscriptional programming of the dendritic cell network
Belz, G. T., & Nutt, S. L. (2012) · Nature Reviews Immunology · doi:10.1038/nri3149 · Cited by 282
“1 is an attractive candidate for being a crucial regulator of the DC lineages, as it is expressed by all DCs and by CDP”
BackgroundSelf-citationCarotta, S., Dakic, A., D'Amico, A., Pang, S. H. M., Greig, K. T., Nutt, S. L., & Wu, L. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.005 · Cited by 279
“Within the DC lineage, Sfpi1shows a bimodal expression pattern, being highly expressed by conventional DCs (cDCs) but present in low amounts in plasmacytoid DCs (pDCs) (Back et al., 2005; Nutt et al., 2005).”
BackgroundMethodInfluentialSelf-citationA microRNA expression signature of osteoclastogenesis
Sugatani, T., Vacher, J., & Hruska, K. A. (2011) · Blood · doi:10.1182/blood-2010-10-311415 · Cited by 275
“1 is expressed in hematopoietic stem cells, CMPs, and the common lymphoid progenitors at the same levels and is present at high levels in mature myeloid cells.(35,36) PU.”
BackgroundPositive Feedback Between PU.1 and the Cell Cycle Controls Myeloid Differentiation
Kueh, H. Y., Champhekar, A., Nutt, S. L., Elowitz, M. B., & Rothenberg, E. V. (2013) · Science · doi:10.1126/science.1240831 · Cited by 273
“1-GFP knock-in reporter (2), cultured them with cytokines supporting B-cell and macrophage differentiation, and analyzed PU.”
Self-citationPU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
Huang, G., Zhang, P., Hirai, H., Elf, S., Yan, X., Chen, Z., Koschmieder, S., Okuno, Y., Dayaram, T., Growney, J. D., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.7 · Cited by 259
Boyer, S. W., Schroeder, A. V., Smith-Berdan, S., & Forsberg, E. C. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.04.021 · Cited by 247
“GFP percentages in Plts (black line), GMs, and B and T cells (not shown) remain unchanged over time in unirradiated mice.”
InfluentialPongubala, J. M. R., Northrup, D. L., Lancki, D. W., Medina, K. L., Treiber, T., Bertolino, E., Thomas, M., Grosschedl, R., Allman, D., & Singh, H. (2008) · Nature Immunology · doi:10.1038/ni1555 · Cited by 249
Forsberg, E. C., Serwold, T., Kogan, S., Weissman, I. L., & Passegué, E. (2006) · Cell · doi:10.1016/j.cell.2006.06.037 · Cited by 213
“Some latent but normally unused lineage plasticity remains at these early stages of lineage commitment as CLP, pro-T, and some early pro-B cells are able to revert to myeloid fates upon specific transgene expression and transcription factor inactivation or overexpression ( Nutt et al., 1999; Kondo et al., 2000; King e…”
Mueller, B. U., Pabst, T., Fos, J., Petkovic, V., Fey, M. F., Asou, N., Buergi, U., & Tenen, D. G. (2006) · Blood · doi:10.1182/blood-2005-07-3068 · Cited by 207
Decker, T., Pasca di Magliano, M., McManus, S., Sun, Q., Bonifer, C., Tagoh, H., & Busslinger, M. (2009) · Immunity · doi:10.1016/j.immuni.2009.01.012 · Cited by 194
“These data therefore indicated that DNA demethylation of Pax5 enhancer sequences occurs either before or at the onset of hematopoiesis in HSCs, whereas DNA methylation seems to play no role in the epigenetic regulation of the Pax5 promoter region.”
BackgroundInfluentialSpooner, C. J., Cheng, J. X., Pujadas, E., Laslo, P., & Singh, H. (2009) · Immunity · doi:10.1016/j.immuni.2009.07.011 · Cited by 188
“1 is a member of the Ets family of transcription factors and is expressed in multiple lineages of the hematopoietic system, including MPPs (Nutt et al., 2005).”
BackgroundPU.1 controls fibroblast polarization and tissue fibrosis
Wohlfahrt, T., Rauber, S., Uebe, S., Luber, M., Soare, A., Ekici, A., Weber, S., Matei, A.-E., Chen, C.-W., Maier, C., et al. (2019) · Nature · doi:10.1038/s41586-019-0896-x · Cited by 187
Self-citationShimokawa, C., Kanaya, T., Hachisuka, M., Ishiwata, K., Hisaeda, H., Kurashima, Y., Kiyono, H., Yoshimoto, T., Kaisho, T., & Ohno, H. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.017 · Cited by 188
The Branching Point in Erythro-Myeloid Differentiation
Perié, L., Duffy, K. R., Kok, L., de Boer, R. J., & Schumacher, T. N. (2015) · Cell · doi:10.1016/j.cell.2015.11.059 · Cited by 185
“Reports of unequal output of GM or MkE progenitors by subsets of CMPs (Iwasaki et al., 2005; Nutt et al., 2005; Terszowski et al., 2005) suggest a separation between the erythroid and myeloid lineages earlier than the CMP stage.”
The role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesis
Burda, P., Laslo, P., & Stopka, T. (2010) · Leukemia · doi:10.1038/leu.2010.104 · Cited by 184
Identification of the earliest NK-cell precursor in the mouse BM
Carotta, S., Pang, S. H. M., Nutt, S. L., & Belz, G. T. (2011) · Blood · doi:10.1182/blood-2010-11-318956 · Cited by 183
Self-citationThomas, T., Corcoran, L. M., Gugasyan, R., Dixon, M. P., Brodnicki, T., Nutt, S. L., Metcalf, D., & Voss, A. K. (2006) · Genes & Development · doi:10.1101/gad.1382606 · Cited by 181
“lations were isolated by FACS based on their cell surface marker profile as described previously (Nutt et al. 2005).”
Self-citationTranscriptional Networks Driving Dendritic Cell Differentiation and Function
Nutt, S. L., & Chopin, M. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.005 · Cited by 163
Self-citationSima, C., & Glogauer, M. (2013) · Periodontology 2000 · doi:10.1111/prd.12032 · Cited by 163
Identification of Pax5 Target Genes in Early B Cell Differentiation
Pridans, C., Holmes, M. L., Polli, M., Wettenhall, J. M., Dakic, A., Corcoran, L. M., Smyth, G. K., & Nutt, S. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1719 · Cited by 162
“HSC, common lymphoid progenitor (CLP), and B cell populations were sorted as previously described (26, 27).”
MethodSelf-citationOnai, N., Obata-Onai, A., Tussiwand, R., Lanzavecchia, A., & Manz, M. G. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051645 · Cited by 156
“1 expression was recently mapped in early hematopoietic progenitor cells (46).”
BackgroundThe transcription factors IRF8 and PU.1 negatively regulate plasma cell differentiation
Carotta, S., Willis, S. N., Hasbold, J., Inouye, M., Pang, S. H. M., Emslie, D., Light, A., Chopin, M., Shi, W., Wang, H., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140425 · Cited by 155
“Spi1 fl-gfp (the floxed allele that also contains GFP knock-in into the 3 untranslated region) and Spi1 fl/fl Cd19 Cre (PU.1cKO) were generated by our group previously (Nutt et al., 2005; Polli et al., 2005).”
MethodSelf-citationDeciphering the Innate Lymphoid Cell Transcriptional Program
Seillet, C., Mielke, L. A., Amann-Zalcenstein, D. B., Su, S., Gao, J., Almeida, F. F., Shi, W., Ritchie, M. E., Naik, S. H., Huntington, N. D., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.025 · Cited by 146
“1+EomesmCherry (Kara et al., 2015), Pcdc1 / (Keir et al., 2007), Irf8egfp (Wang et al., 2014), and PU.1gfp (Nutt et al., 2005) mice have been described previously.”
IRF8 regulates B-cell lineage specification, commitment, and differentiation
Wang, H., Lee, C. H., Qi, C., Tailor, P., Feng, J., Abbasi, S., Atsumi, T., & Morse, H. C. (2008) · Blood · doi:10.1182/blood-2008-01-129049 · Cited by 144
Chen, B., Jiang, L., Zhong, M.-L., Li, J.-F., Li, B.-S., Peng, L.-J., Dai, Y.-T., Cui, B.-W., Yan, T.-Q., Zhang, W.-N., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717125115 · Cited by 142
“With regard to transcriptome analyses, SPI1 overexpression is noteworthy, since it serves as a regulator for MEF2C expression in normal lymphoid development and is highly expressed in prethymic progenitors (34).”
BackgroundRecurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia
Seki, M., Kimura, S., Isobe, T., Yoshida, K., Ueno, H., Nakajima-Takagi, Y., Wang, C., Lin, L., Kon, A., Suzuki, H., et al. (2017) · Nature Genetics · doi:10.1038/ng.3900 · Cited by 138
Cattoretti, G., Shaknovich, R., Smith, P. M., Jäck, H.-M., Murty, V. V., & Alobeid, B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6930 · Cited by 134
“1, a member of the large ets family of TF (7), enforces the B cell lineage commitment by limiting other differentiation choices (7, 8), and is then expressed along the B cell, but not the plasma cell lineage (9), together with other B cell-specific TF (9, 10).”
BackgroundTwo distinct auto-regulatory loops operate at the PU.1 locus in B cells and myeloid cells
Leddin, M., Perrod, C., Hoogenkamp, M., Ghani, S., Assi, S., Heinz, S., Wilson, N. K., Follows, G., Schönheit, J., Vockentanz, L., et al. (2011) · Blood · doi:10.1182/blood-2010-08-302976 · Cited by 131
“1 levels and primary B cells expressing intermediate levels.(37) In macrophages, we confirmed the presence of the previously published DHSs at the proximal PU.”
BackgroundMacrophages and Cardiovascular Health
Frodermann, V., & Nahrendorf, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00068.2017 · Cited by 127
Single-cell epigenomic variability reveals functional cancer heterogeneity
Litzenburger, U. M., Buenrostro, J. D., Wu, B., Shen, Y., Sheffield, N. C., Kathiria, A., Greenleaf, W. J., & Chang, H. Y. (2017) · Genome Biology · doi:10.1186/s13059-016-1133-7 · Cited by 115
“1 is a key regulator of hematopoietic differentiation, which is tightly regulated transcriptionally and not expressed in differentiated erythroid or myeloid cells [44] and thus implicates CD24 as a less differentiated “stem-like” subpopulation.”
BackgroundHoogenkamp, M., Lichtinger, M., Krysinska, H., Lancrin, C., Clarke, D., Williamson, A., Mazzarella, L., Ingram, R., Jorgensen, H., Fisher, A., et al. (2009) · Blood · doi:10.1182/blood-2008-11-191890 · Cited by 121
Regulation of Lymphoid versus Myeloid Fate 'choice' by the Transcription Factor Mef2c
Stehling-Sun, S., Dade, J., Nutt, S. L., DeKoter, R. P., & Camargo, F. D. (2009) · Nature Immunology · doi:10.1038/ni.1694 · Cited by 125
Self-citationCaminschi, I., Ahmet, F., Heger, K., Brady, J., Nutt, S. L., Vremec, D., Pietersz, S., Lahoud, M. H., Schofield, L., Hansen, D. S., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071351 · Cited by 121
Self-citationLangerhans cells are generated by two distinct PU.1-dependent transcriptional networks
Chopin, M., Seillet, C., Chevrier, S., Wu, L., Wang, H., Morse, H. C., Belz, G. T., & Nutt, S. L. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130930 · Cited by 119
“Both CD11cMHCII and CD11c+MHCII cells lacked PU.1GFP and expressed ID2GFP constitutively, whereas the CD11c+MHCII+ LCs expressed high levels of PU.1 and ID2.”
MethodInfluentialSelf-citationRegulation of plasmacytoid dendritic cell development
Reizis, B. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.005 · Cited by 117
“1 is expressed in PDC at moderate levels (compared to high-level expression in cDC) [49], and its role in PDC development remains to be established.”
BackgroundSteidl, U., Steidl, C., Ebralidze, A., Chapuy, B., Han, H.-J., Will, B., Rosenbauer, F., Becker, A., Wagner, K., Koschmieder, S., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30525 · Cited by 114
A role of stochastic phenotype switching in generating mosaic endothelial cell heterogeneity
Yuan, L., Chan, G. C. T., Beeler, D. L., Janes, L., Spokes, K., Dharaneeswaran, H., Mojiri, A., Adams, W. J., Sciuto, T. E., García‐Cardeña, G., et al. (2016) · Nature Communications · doi:10.1038/ncomms10160 · Cited by 121
“8b, there was a strong correlation between Vwf and lacZ mRNA numbers in individual cells, arguing against independent switching of the two alleles and in accord with previous reports for other loci 50,51 .”
van Oevelen, C., Collombet, S., Vicent, G., Hoogenkamp, M., Lepoivre, C., Badeaux, A., Bussmann, L., Sardina, J. L., Thieffry, D., Beato, M., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.06.007 · Cited by 105
“…the factor; (2) PU.1 is expressed in stem and progenitor cells, but downregulated in T cells and Erys (Back et al., 2005; Lara-Astiaso et al., 2014; Nutt et al., 2005), and this strongly correlates with the distribution of pre-existing myeloid enhancers and the expression of nearby genes; and…”
BackgroundChopin, M., Lun, A. T., Zhan, Y., Schreuder, J., Coughlan, H., D’Amico, A., Mielke, L. A., Almeida, F. F., Kueh, A. J., Dickins, R. A., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.11.010 · Cited by 104
Self-citationCarreras, E., Turner, S., Frank, M. B., Knowlton, N. S., Osban, J., Centola, M. B., Park, C. G., Simmons, A., Alberola‐Ila, J., & Kovats, S. (2009) · Blood · doi:10.1182/blood-2009-08-236935 · Cited by 115
Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside
Deutsch, V. R., & Tomer, A. (2013) · British Journal of Haematology · doi:10.1111/bjh.12328 · Cited by 122
“Two major transcription factors involved in CMP differentiation are GATA-1 (GATA1), which drives MEP development and PU.1 (SPI1), which regulates granulocyte-monocyte precursors (Nutt et al, 2005).”
BackgroundPU.1: A crucial and versatile player in hematopoiesis and leukemia
Kastner, P., & Chan, S. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.01.026 · Cited by 101
The Transcription Factor PU.1 is a Critical Regulator of Cellular Communication in the Immune System
Turkistany, S. A., & DeKoter, R. P. (2011) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-011-0147-9 · Cited by 96
“1 expression in the hematopoietic system has been studied by a combination of techniques, including most recently, reporter alleles ‘‘knocked in’’ to the Sfpi1 locus in mice (Back et al. 2005; Colucci et al. 2001; Hromas et al. 1993; Nelsen et al. 1993; Nutt et al. 2005).”
BackgroundTranscription factor PU.1 and immune cell differentiation (Review)
Li, G., Hao, W., & Hu, W. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4763 · Cited by 98
“In comparison, plasmacy-toid DCs (pDCs) characteristically expressed a low level (11).”
Monocyte Differentiation and Heterogeneity: Inter-Subset and Interindividual Differences
Williams, H., Mack, C. D., Baraz, R., Marimuthu, R., Naralashetty, S., Li, S., & Medbury, H. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108757 · Cited by 119
“transcription factor, which independently produced precursors for GMP or MEP [26].”
BackgroundInfluentialEffect of transcription-factor concentrations on leukemic stem cells
Rosenbauer, F., Koschmieder, S., Steidl, U., & Tenen, D. G. (2005) · Blood · doi:10.1182/blood-2005-02-0717 · Cited by 98
On the Way to Become a Natural Killer Cell
Vito, C. D., Mikulak, J., & Mavilio, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01812 · Cited by 108
Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified
Ji, M.-M., Huang, Y., Huang, J.-Y., Wang, Z., Fu, D., Liu, H., Liu, F., Lebœuf, C., Wang, L., Ye, J., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.182444 · Cited by 104
Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis
Khodadi, E., Asnafi, A. A., Shahrabi, S., Shahjahani, M., & Saki, N. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2703-1 · Cited by 96
“In particular, GATA-1 regulates MEP growth, while PU-1 is implicated in differentiation regulation of granulocytemonocyte precursors [12, 19].”
BackgroundInfluentialInactivation of PU.1 in adult mice leads to the development of myeloid leukemia
Metcalf, D., Dakic, A., Mifsud, S., Di Rago, L., Wu, L., & Nutt, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510616103 · Cited by 95
Self-citationThe Endless Saga of Monocyte Diversity
Canè, S., Ugel, S., Trovato, R., Marigo, I., Sanctis, F. D., Sartoris, S., & Bronte, V. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01786 · Cited by 107
“Circulating monocytes have been viewed for many years, as precursor cells that provide tissue macrophages and dendritic cell (DCs) populations (8, 9); however, mounting evidence suggests that monocytes have their own effector functions in the blood and at peripheral sites throughout the body (10).”
BackgroundInfluentialArchitecture of a lymphomyeloid developmental switch controlled by PU.1, Notch and Gata3
Del Real, M. M., & Rothenberg, E. V. (2013) · Development · doi:10.1242/dev.088559 · Cited by 95
“1 (Sfpi1 – Mouse Genome Informatics) is important during early T-cell development (Back et al., 2005; Nutt et al., 2005), and is highly expressed initially but repressed during commitment (Fig.”
BackgroundC1 Complex: An Adaptable Proteolytic Module for Complement and Non-Complement Functions
Lu, J., & Kishore, U. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00592 · Cited by 103
“PU.1 and IRF8, especially PU.1, is a key transcription factor that defines the macrophage and DC lineage of hematopoietic development (88).”
Differentiation-based model of hematopoietic stem cell functions and lineage pathways
Höfer, T., & Rodewald, H.-R. (2018) · Blood · doi:10.1182/blood-2018-03-791517 · Cited by 104
Surprising new roles for PU.1 in the adaptive immune response
Carotta, S., Wu, L., & Nutt, S. L. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00955.x · Cited by 93
“During early thymic development, PU.1 is expressed in the DN1 and DN2 stages before being shutoff just before DN3 (6) (Fig.”
BackgroundMethodInfluentialSelf-citationMetcalf, D. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0544 · Cited by 91
Self-citationYe, M., Ermakova, O., & Graf, T. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051089 · Cited by 90
“1 plays a role at later stages of B cell differentiation, where the gene is also expressed (9).”
BackgroundThe development of functional B lymphocytes in conditional PU.1 knock-out mice
Polli, M., Dakic, A., Light, A., Wu, L., Tarlinton, D. M., & Nutt, S. L. (2005) · Blood · doi:10.1182/blood-2005-01-0283 · Cited by 90
Self-citationT Cell Lineage Commitment: Identity and Renunciation
Rothenberg, E. V. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003703 · Cited by 89
“1 (32), which is also essential for generation of lymphoid-primed multipotent precursors (33,34).”
BackgroundTranscriptional Control of Natural Killer Cell Development and Function
Hesslein, D. G. T., & Lanier, L. L. (2011) · Advances in immunology · doi:10.1016/b978-0-12-387664-5.00002-9 · Cited by 95
“In contrast, Nutt et al. (2005) did not detect GFP expression in NK cells isolated from the spleens of a PU.1-specific GFP reporter mouse strain.”
Heterogeneity of Flt3-Expressing Multipotent Progenitors in Mouse Bone Marrow
Lai, A. Y., Lin, S. M., & Kondo, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5016 · Cited by 89
“(26) recently showed that the CMP population is heterogeneous, and only Flt3 CMPs have MegE differentiation potential.”
BackgroundRothenberg, E. V. (2007) · Immunity · doi:10.1016/j.immuni.2007.06.005 · Cited by 96
Wang, H., Jain, S., Li, P., Lin, J.-X., Oh, J., Qi, C., Gao, Y., Sun, J., Sakai, T., Naghashfar, Z., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901258116 · Cited by 81
“1 is also constitutively expressed in BM-developing B cells and splenic naïve B cells (18).”
BackgroundSelf-citationGATA-3 Dose-Dependent Checkpoints in Early T Cell Commitment
Scripture-Adams, D. D., Damle, S. S., Li, L., Elihu, K. J., Qin, S., Arias, A. M., Butler, R. R., Champhekar, A., Zhang, J. A., & Rothenberg, E. V. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301663 · Cited by 81
CellOracle: Dissecting cell identity via network inference and in silico gene perturbation
Kamimoto, K., Hoffmann, C. M., & Morris, S. A. (2020) · doi:10.1101/2020.02.17.947416 · Cited by 81
New Advances and Contributions to Fish Biology
Türker, H. (2012) · InTech eBooks · doi:10.5772/45635 · Cited by 86
PU.1 and Haematopoietic Cell Fate: Dosage Matters
Mak, K. S., Funnell, A. P. W., Pearson, R. C. M., & Crossley, M. (2011) · International Journal of Cell Biology · doi:10.1155/2011/808524 · Cited by 77
“This may also explain why PU.1 expression must be downregulated during erythropoiesis to allow normal production of RBCs.”
BackgroundInfluentialUngerbäck, J., Hosokawa, H., Wang, X., Strid, T., Williams, B. A., Sigvardsson, M., & Rothenberg, E. V. (2018) · Genome Research · doi:10.1101/gr.231423.117 · Cited by 77
“PU.1 is also crucial for multiple other hematopoietic lineages (Back et al. 2005; Iwasaki et al. 2005; Nutt et al. 2005) including the earliest stages of T-cell development (Champhekar et al. 2015).”
Background2014 Jeffrey M. Hoeg Award Lecture: Transcriptional Control of Monocyte Development
Zhu, Y. P., Thomas, G. D., & Hedrick, C. C. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.304054 · Cited by 89
“1 gene is expressed at low levels in CMP in BM, and its expression increases as cells differentiate into either monocytes or neutrophils.(60) PU.”
BackgroundEarly decisions in lymphoid development
Ye, M., & Graf, T. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.02.007 · Cited by 94
Champhekar, A., Damle, S. S., Freedman, G., Carotta, S., Nutt, S. L., & Rothenberg, E. V. (2015) · Genes & Development · doi:10.1101/gad.259879.115 · Cited by 74
“…differ in erythroidcells,myeloidcells,Bcells, andearlyTcells (Ghisletti et al. 2010; Heinz et al. 2010; Wontakal et al. 2011, 2012;Ridinger-Saisonet al. 2012;Zhanget al. 2012;Ostuni et al. 2013), but in all of these cases, the majority of the binding sites detected are likely to be nonfunctional.”
BackgroundSelf-citationWang, H., Yan, M., Sun, J., Jain, S., Yoshimi, R., Abolfath, S. M., Ozato, K., Coleman, W. G., Ng, A. P., Metcalf, D., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301939 · Cited by 72
“3A, left panel), both of which lie within the CMP fraction that we had characterized previously (32, 33).”
BackgroundSelf-citationIs PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?
Dakic, A., Wu, L., & Nutt, S. L. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.006 · Cited by 72
Self-citationInnate immune regulation by STAT ‐mediated transcriptional mechanisms
Li, H. S., & Watowich, S. S. (2014) · Immunological Reviews · doi:10.1111/imr.12198 · Cited by 77
Katsumoto, T., Yoshida, N., & Kitabayashi, I. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00865.x · Cited by 79
Pang, S. H. M., de Graaf, C. A., Hilton, D. J., Huntington, N. D., Carotta, S., Wu, L., & Nutt, S. L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01264 · Cited by 60
“Mice The Spi1gfp (floxed exon 5 of Spi1 and a GFP knockin into the 3′ untranslated region) (16), Spi1fl/−MxCre+ (35), Rag1gfp/+ (36), Rag1cre/+ (37), and Rosa26-CreERT2 (38) mice have been previously described.”
BackgroundInfluentialSelf-citationEdvardsson, L., Dykes, J. H., & Olofsson, T. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.01.017 · Cited by 64
Chen, G., Tan, C. S., Teh, B. K., & Lu, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.286427 · Cited by 71
Epigenetic program and transcription factor circuitry of dendritic cell development
Lin, Q., Chauvistré, H., Costa, I. G., Gusmao, E. G., Mitzka, S., Hänzelmann, S., Baying, B., Klisch, T., Moriggl, R., Hennuy, B., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1056 · Cited by 75
Differential involvement of PU.1 and Id2 downstream of TGF-β1 during Langerhans-cell commitment
Heinz, L. X., Platzer, B., Reisner, P. M., Jörgl, A., Taschner‐Mandl, S., Göbel, F., & Strobl, H. (2005) · Blood · doi:10.1182/blood-2005-04-1721 · Cited by 67
Towards an understanding of the transcription factor network of dendritic cell development
Zenke, M., & Hieronymus, T. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.12.007 · Cited by 74
Won, H., Nandakumar, V., Yates, P., Sanchez, S., Jones, L. E., Huang, X. F., & Chen, S. (2014) · Blood · doi:10.1182/blood-2013-10-534313 · Cited by 67
Metadata
- Authors
- Nutt, S. L., Metcalf, D., D'Amico, A., Polli, M., & Wu, L.
- Affiliations
- Walter and Eliza Hall Institute of Medical Research (AU)
- The Walter and Eliza Hall Institute of Medical Research, Victoria 3050, Australia
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2005-01-17
- Volume
- 201
- Issue
- 2
- Pages
- 221-231
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2212785
- OpenAlex
- W2134220401
- Cited by
- 325
- References
- 48
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 11 · 2023: 10 · 2022: 6 · 2021: 7 · 2020: 15 · 2019: 19 · 2018: 18 · 2017: 22 · 2016: 14 · 2015: 16 · 2014: 19 · 2013: 14 · 2012: 22
- FWCI
- 13.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (CA22556)
- Medical Research Council
- National Health and Medical Research Council
- Cancer Council Victoria
- National Cancer Institute (R37CA022556, CA22556, R01CA022556)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- PU.1, ETS transcription factors, hematopoietic progenitor cells, common myeloid progenitors, FLT3, common lymphoid progenitors, hematopoietic stem cells, CFU-GM, megakaryocyte-erythrocyte progenitors, lineage restriction, erythroid differentiation, megakaryopoiesis, fetal liver hematopoiesis, transcriptional regulation
- MeSH terms
- Proto-Oncogene Protein Spi-1, Animals, Bone Marrow Cells, Hematopoietic Stem Cells, Proto-Oncogene Proteins, Thymus Gland, Trans-Activators, Genes, Reporter, Gene Expression Regulation, Developmental, Multipotent Stem Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.